GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MYND Life Sciences Inc (XCNQ:MYND) » Definitions » Net Margin %

MYND Life Sciences (XCNQ:MYND) Net Margin % : 0.00% (As of Jul. 2024)


View and export this data going back to 2021. Start your Free Trial

What is MYND Life Sciences Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. MYND Life Sciences's Net Income for the three months ended in Jul. 2024 was C$-0.38 Mil. MYND Life Sciences's Revenue for the three months ended in Jul. 2024 was C$0.00 Mil. Therefore, MYND Life Sciences's net margin for the quarter that ended in Jul. 2024 was 0.00%.

The historical rank and industry rank for MYND Life Sciences's Net Margin % or its related term are showing as below:


XCNQ:MYND's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -140.3
* Ranked among companies with meaningful Net Margin % only.

MYND Life Sciences Net Margin % Historical Data

The historical data trend for MYND Life Sciences's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MYND Life Sciences Net Margin % Chart

MYND Life Sciences Annual Data
Trend Oct21 Oct22 Oct23
Net Margin %
- - -

MYND Life Sciences Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of MYND Life Sciences's Net Margin %

For the Biotechnology subindustry, MYND Life Sciences's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MYND Life Sciences's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MYND Life Sciences's Net Margin % distribution charts can be found below:

* The bar in red indicates where MYND Life Sciences's Net Margin % falls into.



MYND Life Sciences Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

MYND Life Sciences's Net Margin for the fiscal year that ended in Oct. 2023 is calculated as

Net Margin=Net Income (A: Oct. 2023 )/Revenue (A: Oct. 2023 )
=-1.518/0
= %

MYND Life Sciences's Net Margin for the quarter that ended in Jul. 2024 is calculated as

Net Margin=Net Income (Q: Jul. 2024 )/Revenue (Q: Jul. 2024 )
=-0.379/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MYND Life Sciences  (XCNQ:MYND) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


MYND Life Sciences Net Margin % Related Terms

Thank you for viewing the detailed overview of MYND Life Sciences's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


MYND Life Sciences Business Description

Traded in Other Exchanges
Address
105-2248 Elgin Avenue, Port Coquitlam, BC, CAN, V3C 2B2
MYND Life Sciences Inc is a medical biotech drug research and development company. The company is focused on neuro pharmaceutical and novel drug development, diagnostics, and vaccines and is developing new biological entities (NBEs) and new chemical entities (NCEs) and differentiates itself from other (bio)pharmaceutical companies by different molecular concepts for the applications of psilocybin analogs for overcoming diseases.